Búsqueda | Portal de Búsqueda de la BVS Ecuador

1.

Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C⁺ NK cells to target myeloid leukemia.

Chiu, Emily; Felices, Martin; Cichocki, Frank; Davis, Zachary; Wang, Hongbo; Tuninga, Katie; Vallera, Daniel A; Lee, Tom; Bjordahl, Ryan; Malmberg, Karl Johan; Valamehr, Bahram; Miller, Jeffrey S.

Mol Ther ; 29(12): 3410-3421, 2021 12 01.

Artículo en Inglés | MEDLINE | ID: mdl-34174441

2.

Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.

Davis, Zachary B; Vallera, Daniel A; Miller, Jeffrey S; Felices, Martin.

Semin Immunol ; 31: 64-75, 2017 06.

Artículo en Inglés | MEDLINE | ID: mdl-28882429

3.

Early Reconstitution of NK and Î³Î´ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.

de Witte, Moniek A; Sarhan, Dhifaf; Davis, Zachary; Felices, Martin; Vallera, Daniel A; Hinderlie, Peter; Curtsinger, Julie; Cooley, Sarah; Wagner, John; Kuball, Jurgen; Miller, Jeffrey S.

Biol Blood Marrow Transplant ; 24(6): 1152-1162, 2018 06.

Artículo en Inglés | MEDLINE | ID: mdl-29505821

4.

Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker.

Schmohl, Joerg U; Felices, Martin; Taras, Elizabeth; Miller, Jeff S; Vallera, Daniel A.

Mol Ther ; 24(7): 1312-22, 2016 08.

Artículo en Inglés | MEDLINE | ID: mdl-27157665

5.

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

Gleason, Michelle K; Ross, Julie A; Warlick, Erica D; Lund, Troy C; Verneris, Michael R; Wiernik, Andres; Spellman, Stephen; Haagenson, Michael D; Lenvik, Alexander J; Litzow, Mark R; Epling-Burnette, Pearlie K; Blazar, Bruce R; Weiner, Louis M; Weisdorf, Daniel J; Vallera, Daniel A; Miller, Jeffrey S.

Blood ; 123(19): 3016-26, 2014 May 08.

Artículo en Inglés | MEDLINE | ID: mdl-24652987

6.

Prosthetic Antigen Receptors.

Shen, Jingjing; Vallera, Daniel A; Wagner, Carston R.

J Am Chem Soc ; 137(32): 10108-11, 2015 Aug 19.

Artículo en Inglés | MEDLINE | ID: mdl-26230248

7.

Hemangiosarcoma and its cancer stem cell subpopulation are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors.

Schappa, Jill T; Frantz, Aric M; Gorden, Brandi H; Dickerson, Erin B; Vallera, Daniel A; Modiano, Jaime F.

Int J Cancer ; 133(8): 1936-44, 2013 Oct 15.

Artículo en Inglés | MEDLINE | ID: mdl-23553371

8.

Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.

Skubitz, Amy P N; Taras, Elizabeth P; Boylan, Kristin L M; Waldron, Nate N; Oh, Seunguk; Panoskaltsis-Mortari, Angela; Vallera, Daniel A.

Gynecol Oncol ; 130(3): 579-87, 2013 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-23721800

9.

Diphtheria toxin-based targeted toxin therapy for brain tumors.

Li, Yan Michael; Vallera, Daniel A; Hall, Walter A.

J Neurooncol ; 114(2): 155-64, 2013 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-23695514

10.

Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings.

Petersburg, Jacob; Vallera, Daniel A; Wagner, Carston R.

Mol Cancer Ther ; 22(3): 371-380, 2023 03 02.

Artículo en Inglés | MEDLINE | ID: mdl-36548194

11.

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer.

Kennedy, Philippa R; Vallera, Daniel A; Ettestad, Brianna; Hallstrom, Caroline; Kodal, Behiye; Todhunter, Deborah A; Bendzick, Laura; Hinderlie, Peter; Walker, Joshua T; Pulkrabek, Brittany; Pastan, Ira; Kratzke, Robert A; Fujioka, Naomi; Miller, Jeffrey S; Felices, Martin.

Front Immunol ; 14: 1060905, 2023.

Artículo en Inglés | MEDLINE | ID: mdl-36911670

12.

Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.

Zhou, Qing; Munger, Meghan E; Highfill, Steven L; Tolar, Jakub; Weigel, Brenda J; Riddle, Megan; Sharpe, Arlene H; Vallera, Daniel A; Azuma, Miyuki; Levine, Bruce L; June, Carl H; Murphy, William J; Munn, David H; Blazar, Bruce R.

Blood ; 116(14): 2484-93, 2010 Oct 07.

Artículo en Inglés | MEDLINE | ID: mdl-20570856

13.

Intracerebral infusion of the bispecific targeted toxin DTATEGF in a mouse xenograft model of a human metastatic non-small cell lung cancer.

Huang, Jun; Li, Yan Michael; Massague, Joan; Sicheneder, Andy; Vallera, Daniel A; Hall, Walter A.

J Neurooncol ; 109(2): 229-38, 2012 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-22696210

14.

Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia.

Ustun, Celalettin; Williams, Sarah; Skendzel, Sasha; Kodal, Behiye; Arock, Michel; Gotlib, Jason; Vallera, Daniel A; Cooley, Sarah; Felices, Martin; Weisdorf, Daniel; Miller, Jeffrey.

Am J Hematol ; 92(5): E66-E68, 2017 May.

Artículo en Inglés | MEDLINE | ID: mdl-28187525

15.

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia.

Zhou, Qing; Bucher, Christoph; Munger, Meghan E; Highfill, Steven L; Tolar, Jakub; Munn, David H; Levine, Bruce L; Riddle, Megan; June, Carl H; Vallera, Daniel A; Weigel, Brenda J; Blazar, Bruce R.

Blood ; 114(18): 3793-802, 2009 Oct 29.

Artículo en Inglés | MEDLINE | ID: mdl-19724059

16.

A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature.

Tsai, Alexander K; Oh, Seunguk; Chen, Hua; Shu, Yanqun; Ohlfest, John R; Vallera, Daniel A.

J Neurooncol ; 103(2): 255-66, 2011 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-20830604

17.

A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer.

Vallera, Daniel A; Oh, Felix; Kodal, Behiye; Hinderlie, Peter; Geller, Melissa A; Miller, Jeffrey S; Felices, Martin.

Cancers (Basel) ; 13(16)2021 Aug 08.

Artículo en Inglés | MEDLINE | ID: mdl-34439149

18.

A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells.

Arvindam, Upasana Sunil; van Hauten, Paulien M M; Schirm, Dawn; Schaap, Nicolaas; Hobo, Willemijn; Blazar, Bruce R; Vallera, Daniel A; Dolstra, Harry; Felices, Martin; Miller, Jeffrey S.

Leukemia ; 35(6): 1586-1596, 2021 06.

Artículo en Inglés | MEDLINE | ID: mdl-33097838

19.

Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation.

Davis, Zachary; Felices, Martin; Lenvik, Todd; Badal, Sujan; Walker, Joshua T; Hinderlie, Peter; Riley, James L; Vallera, Daniel A; Blazar, Bruce R; Miller, Jeffrey S.

Blood Adv ; 5(4): 1069-1080, 2021 02 23.

Artículo en Inglés | MEDLINE | ID: mdl-33599743

20.

Chemically self-assembled antibody nanorings (CSANs): design and characterization of an anti-CD3 IgM biomimetic.

Li, Qing; So, Christopher R; Fegan, Adrian; Cody, Vivian; Sarikaya, Mehmet; Vallera, Daniel A; Wagner, Carston R.

J Am Chem Soc ; 132(48): 17247-57, 2010 Dec 08.

Artículo en Inglés | MEDLINE | ID: mdl-21077608

Portal de Búsqueda de la BVS Ecuador

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: